Determination of reference intervals from a laboratory database of an academic clinical research unit in a tertiary care teaching hospital and an audit of out of range values
- PMID: 34760646
- PMCID: PMC8525794
- DOI: 10.4103/picr.PICR_71_20
Determination of reference intervals from a laboratory database of an academic clinical research unit in a tertiary care teaching hospital and an audit of out of range values
Abstract
Background: Abnormal laboratory values are a common reason for the exclusion of participants in clinical studies, increasing the recruitment time and cost during conduct. The use of sample-specific reference intervals (RIs) may help to address this issue. Hence, the present study derived site-specific RIs using the department laboratory database and compare the proportion of "out of range" (OOR) values between the new and the old RIs used by the trial site.
Methods: Institutional ethics committee approval was obtained. Data for hematology and biochemistry parameters were analyzed. Normality was assessed and RIs computed using nonparametric method. Data were partitioned for gender and descriptive statistics applied for demographics. The OOR values based on new RIs were compared with old RIs using Chi-squared tests. Between gender OOR proportions compared using Chi-squared test (significance at P< 0.05). Post hoc analysis was performed with Beasley's technique.
Results: Data of 601 participants were analyzed. The median (Inter Quartile Range) age was 22 (47) years and 64.72% were male. New RIs for key parameters were: Haemoglobin (9.3-16.5 g/dl), alanine aminotransferase (11.4-47.74 U/I), aspartate aminotransferase (8.8-58 U/I), total bilirubin (0.27-1.4 mg/dl), and creatinine (0.59-1.36 mg/dl). Post partitioning, the RI for hemoglobin (g/dl) was lower (8.72-15.72) in females. The proportion of OOR values were lower with new RIs relative to old laboratory RIs (P < 0.0001).
Conclusion: A reduction in the proportion of OORs and a change in the upper and lower bound laboratory intervals with new RIs emphasize the need for sample-specific ranges to prevent unnecessary exclusions of volunteers from trials.
Keywords: Clinical trials; exclusions; out of range values; reference intervals.
Copyright: © 2021 Perspectives in Clinical Research.
Conflict of interest statement
There are no conflicts of interest.
References
-
- Gogtay NJ, Thatte UM, Kulkarni PS. Frequency and causes for exclusion from randomization of healthy volunteers screened for a phase 1 study in India. Natl Med J India. 2012;25:18–20. - PubMed
-
- Gräsbeck R. Reference values, why and how. Scand J Clin Lab Invest Suppl. 1990;201:45–53. - PubMed
-
- Sibille M, Deigat N, Durieu I, Guillaumont M, Morel D, Bienvenu J, et al. Laboratory data in healthy volunteers: Reference values, reference changes, screening and laboratory adverse event limits in Phase I clinical trials. Eur J Clin Pharmacol. 1999;55:13–9. - PubMed
-
- Pasqualetti G, Gori G, Blandizzi C, Del Tacca M. Healthy volunteers and early phases of clinical experimentation. Eur J Clin Pharmacol. 2010;66:647–53. - PubMed
-
- CLSI and IFCC. C28-A3 Document; Defining, Establishing and Verifying Reference Intervals in the Clinical Laboratory: Approved Guideline. 3rd ed. Vol. 28. Wayne PA, USA: CLSI and IFCC; 2008. pp. 1–76.
LinkOut - more resources
Full Text Sources